What is the difference between Leuprolide and LH?

Leuprolide: Continuous GnRH receptor stimulation causes receptor desensitization and downregulation. This suppresses LH/FSH → testosterone/estrogen to castrate levels. LH: Binds LH receptors on testicular Leydig cells, stimulating the cholesterol → testosterone biosynthetic pathway. In women, the LH surge triggers ovulation and supports luteal phase progesterone production.

Is Leuprolide FDA approved?

Leuprolide is FDA approved (FDA status current as of 1985-04-08). This regulatory status is provided for research and educational context only.

LH is FDA approved (FDA status current as of 2004-10-08). This regulatory status is provided for research and educational context only.

How is Leuprolide administered in research settings?

In research settings, Leuprolide is typically administered via the subcutaneous, intramuscular, or implant routes. PeptideBase does not provide dosing or administration instructions.

How is LH administered in research settings?

In research settings, LH is typically administered via the subcutaneous or intramuscular routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Leuprolide vs LH

Peptide Comparison

Leuprolide vs LH

Both are Reproductive & Hormonal peptides.

Leuprolide

Lupron

Sexual HealthFDA ApprovedPrescription

2 providers listed

Full Leuprolide profile →

LH

Luteinizing Hormone

Sexual HealthFDA ApprovedResearch Only

No providers listed yet

Full LH profile →

Bottom line

Leuprolide carries stronger published evidence (Meta-analysis, 19 key studies) than LH (RCT, 9); both are research compounds.

Quick Verdict

Leuprolide

Evidence

Established Clinical

Evidence

Clinical

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Leuprolide
More provider options (2 vs 0)	Leuprolide

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Leuprolide

Mechanism Family

Reproductive & Hormonal

Half-life

—

FDA Status

approved

Admin Routes

subcutaneous, intramuscular, implant

subcutaneous, intramuscular

Availability

Prescription

Research Only

Providers

2 listed

None listed

FDA Update

Apr 1985

Oct 2004

Avail. Notes

FDA-approved: Lupron (leuprolide acetate), Drugs@FDA application 019010.

—

Research Evidence

Leuprolide

Established ClinicalMeta-analysis · 19 key studies · most recent 2026

ClinicalRCT · 9 key studies · most recent 2026

Research Citations

Leuprolide

Meta-analysis2024 · J Minim Invasive Gynecol

The Effect of Hormonal Treatment on Ovarian Endometriomas: A Systematic Review and Meta-Analysis

RCT1993 · Am J Obstet Gynecol

Depot leuprolide vs danazol for endometriosis: multicenter double-blind RCT

RCT1984 · New England Journal of Medicine

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

Cohort2026 · Int J Mol Sci

Terazosin as a Non-Hormonal Treatment for Endometriosis.

+15 more

Cohort2026 · Vet Res Commun

Effect of recombinant human follicle-stimulating hormone or equine chorionic gonadotropin on the ovarian resp…

Cohort2026 · J Neuroendocrinol

Pulsatile LH release in male and female Sprague Dawley and Wistar rats in different reproductive states.

Review2026 · Neuroendocrinology

Stress as a Neuroendocrine Modulator of the Reproductive Axis: Roles of Glucocorticoids, Kisspeptin and Serot…

Cohort2026 · Genetics

Functional Landscape of Zebrafish Gonadotropins and Receptors: A Comprehensive Genetic Analysis.

+5 more

About Leuprolide

Continuous GnRH receptor stimulation causes receptor desensitization and downregulation. This suppresses LH/FSH → testosterone/estrogen to castrate levels. Short-term pulsatile use can transiently stimulate the axis before suppression occurs.

Research Areas

HPG axis modulationtestosterone suppressionhormonal restartGnRH axis control

About LH

Binds LH receptors on testicular Leydig cells, stimulating the cholesterol → testosterone biosynthetic pathway. In women, the LH surge triggers ovulation and supports luteal phase progesterone production.

Research Areas

testosterone stimulationfertility supportHPG axis supportovulation inductionLeydig cell activation

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Leuprolide

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Find Providers

Where to source these peptides

Providers offering

Leuprolide

2 listed

Browse directory →

Providers offering

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Reproductive & Hormonal Comparisons

Browse all peptides →

Educational research tools — not medical advice.